STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could guide better lung cancer treatment
Disease control Recruiting nowThis study is testing if using a blood test (ctDNA) to guide treatment decisions helps people with advanced lung cancer live longer. All 63 participants will first receive an immunotherapy drug (cemiplimab). After two cycles, doctors will check the blood test results and the pati…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New trial aims to zap lung cancer faster, with fewer side effects
Disease control Recruiting nowThis study is testing if a more precise, faster radiation treatment can better control advanced lung cancer that cannot be surgically removed. It will compare this new approach to the current standard method, both combined with chemotherapy and a year of immunotherapy. The main g…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC